Evidence map›Paper›PMID 31805812›Full record

ArticleCirculation research2020

Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling.

Simon Tual-Chalot, Maria Garcia-Collado, Rachael E Redgrave, Esha Singh, Benjamin Davison, Catherine Park, Hua Lin, Saimir Luli, Yi Jin, Yixin Wang and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Review
  3. Live imaging of vascular dynamics in mouse skin.The Journal of investigative dermatology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Simon Tual-ChalotFrom the Biosciences Institute (S.T.-C., R.E.R., E.S., B.D., C.P., H.L., H.M.A.), Faculty of Medical Sciences, Newcastle University, United Kingdom.
Maria Garcia-ColladoKarolinska Institutet, Solna, Sweden (M.G.-C., Y.J., Y.W., L.J.).
Rachael E RedgraveFrom the Biosciences Institute (S.T.-C., R.E.R., E.S., B.D., C.P., H.L., H.M.A.), Faculty of Medical Sciences, Newcastle University, United Kingdom.
Esha SinghFrom the Biosciences Institute (S.T.-C., R.E.R., E.S., B.D., C.P., H.L., H.M.A.), Faculty of Medical Sciences, Newcastle University, United Kingdom.
Benjamin DavisonFrom the Biosciences Institute (S.T.-C., R.E.R., E.S., B.D., C.P., H.L., H.M.A.), Faculty of Medical Sciences, Newcastle University, United Kingdom.
Catherine ParkFrom the Biosciences Institute (S.T.-C., R.E.R., E.S., B.D., C.P., H.L., H.M.A.), Faculty of Medical Sciences, Newcastle University, United Kingdom.
Hua LinFrom the Biosciences Institute (S.T.-C., R.E.R., E.S., B.D., C.P., H.L., H.M.A.), Faculty of Medical Sciences, Newcastle University, United Kingdom.
Saimir LuliPreclinical In Vivo Imaging Facility (S.L.), Faculty of Medical Sciences, Newcastle University, United Kingdom.
Yi JinKarolinska Institutet, Solna, Sweden (M.G.-C., Y.J., Y.W., L.J.).
Yixin WangKarolinska Institutet, Solna, Sweden (M.G.-C., Y.J., Y.W., L.J.).
Allan LawrieDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, United Kingdom (A.L.).
Lars JakobssonKarolinska Institutet, Solna, Sweden (M.G.-C., Y.J., Y.W., L.J.).
Helen M ArthurFrom the Biosciences Institute (S.T.-C., R.E.R., E.S., B.D., C.P., H.L., H.M.A.), Faculty of Medical Sciences, Newcastle University, United Kingdom.
Newcastle University · GBKarolinska Institutet · SE

Funding

British Heart Foundation FS/09/027/27871British Heart Foundation FS/13/48/30453British Heart Foundation FS/18/52/33808British Heart Foundation PG/14/86/31177British Heart Foundation PG/18/25/33587British Heart Foundation PG/18/57/33941British Heart Foundation RG/12/2/29416
6 · The paper itself

Abstract

rationaleENG (endoglin) is a coreceptor for BMP (bone morphogenetic protein) 9/10 and is strongly expressed in endothelial cells. Mutations in

objectiveThe goal of the work was to determine how ENG maintains vessel caliber in adult life to prevent AVM formation and thereby protect heart function. METHODS AND

resultsGenetic depletion of endothelial

conclusionsENG promotes the normal balance of VEGF signaling in quiescent endothelial cells to maintain vessel caliber-an essential function in conditions of increased VEGF expression such as local hypoxia or inflammation. In the absence of endothelial ENG, increased sensitivity to VEGF drives abnormal endothelial proliferation in local regions of high VEGF expression, leading to AVM formation and a rapid injurious impact on heart function.

Indexed as

AnimalsArteriovenous MalformationsBlood PressureCell ProliferationEndoglinEndothelial CellsEndothelium, VascularFemaleHeart FailureMaleMiceMice, Inbred C57BLSignal TransductionVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2EndoglinEng protein, mouseKdr protein, mouseVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2arteriovenous malformationsendoglinendothelial cellshypoxiavascular diseases

Identifiers

PMID31805812
PMCPMC6970547
OpenAlexW2992689170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.